Compare ALGN & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGN | CHWY |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 13.5B |
| IPO Year | N/A | 2019 |
| Metric | ALGN | CHWY |
|---|---|---|
| Price | $167.81 | $31.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 22 |
| Target Price | ★ $174.00 | $46.00 |
| AVG Volume (30 Days) | 808.8K | ★ 7.1M |
| Earning Date | 02-04-2026 | 12-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.16 | 0.49 |
| Revenue | $3,982,622,000.00 | ★ $12,584,235,000.00 |
| Revenue This Year | $2.58 | $8.36 |
| Revenue Next Year | $3.66 | $8.29 |
| P/E Ratio | ★ $32.48 | $64.62 |
| Revenue Growth | 0.56 | ★ 10.00 |
| 52 Week Low | $122.00 | $29.83 |
| 52 Week High | $234.19 | $48.62 |
| Indicator | ALGN | CHWY |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 41.10 |
| Support Level | $164.44 | $31.75 |
| Resistance Level | $172.36 | $33.99 |
| Average True Range (ATR) | 4.44 | 1.27 |
| MACD | -0.66 | -0.08 |
| Stochastic Oscillator | 51.58 | 9.68 |
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.